NASDAQ: HRZNHorizon Technology Finance Corp Stock
$8.02+0.23 (+2.95%)
Updated Jul 9, 2025
HRZN Price
$8.02
Fair Value Price
$1.85
Market Cap
$323.65M
52 Week Low
$7.09
52 Week High
$12.63
P/E
-8.53x
P/B
1.06x
P/S
3.85x
PEG
N/A
Dividend Yield
15.09%
Revenue
$98.30M
Earnings
-$35.72M
Gross Margin
87.5%
Operating Margin
-1.5%
Profit Margin
-36.3%
Debt to Equity
1.59
Operating Cash Flow
-$13M
Beta
0.67
Next Earnings
Jul 28, 2025
Ex-Dividend
Jun 16, 2025
Next Dividend
Jul 15, 2025
HRZN Overview
Horizon Technology Finance Corporation is a business development company specializing in lending and and investing in development-stage investments. It focuses on making secured debt and venture lending investments to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries. It seeks to invest in companies in the United States.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine HRZN's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
D
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Asset Management
Industry Rating
D
HRZN
Ranked#38 of 84
Ranked#38 of 84
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $45.90 | A | |
| $37.85 | B | |
| $203.83 | B |
Be the first to know about important HRZN news, forecast changes, insider trades & much more!
HRZN News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HRZN scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
HRZN ($8.02) is overvalued by 332.54% relative to our estimate of its Fair Value price of $1.85 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
HRZN ($8.02) is not significantly undervalued (332.54%) relative to our estimate of its Fair Value price of $1.85 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
HRZN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more HRZN due diligence checks available for Premium users.
Valuation
HRZN fair value
Fair Value of HRZN stock based on Discounted Cash Flow (DCF)
Price
$8.02
Fair Value
$1.85
Overvalued by
332.54%
HRZN ($8.02) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
HRZN ($8.02) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
HRZN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
HRZN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-8.53x
Industry
137.43x
Market
30.63x
HRZN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.06x
Industry
3.01x
HRZN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
HRZN's financial health
Profit margin
Revenue
$24.5M
Net Income
-$21.4M
Profit Margin
-87.4%
HRZN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$789.6M
Liabilities
$484.1M
Debt to equity
1.59
HRZN's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
HRZN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$13.2M
Investing
$0.0
Financing
-$10.2M
HRZN vs Asset Management Stocks
Horizon Technology Finance Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.